Treatment of tuberculous meningitis: Overdue for concerted action

被引：4

作者：

Wilkinson, Robert J. ^{[1
,2
,3
,4
]}

Donovan, Joseph ^{[5
]}

Thwaites, Guy E. ^{[6
,7
]}

van Crevel, Reinout ^{[6
,8
,9
]}

Wasserman, Sean ^{[1
,2
]}

机构：

[1] Univ Cape Town, Wellcome Ctr Infect Dis Res Africa, Inst Infect Dis & Mol Med, ZA-7925 Observatory, South Africa

[2] Univ Cape Town, Dept Med, ZA-7925 Observatory, South Africa

[3] Francis Crick Inst, London NW1 1AT, England

[4] Imperial Coll, Dept Infect Dis, London W12 0NN, England

[5] London Sch Hyg & Trop Med, Clin Res Dept, Keppel St, London WC1E 7HT, England

[6] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England

[7] Oxford Univ Clin Res Unit, Ho Chi Minh City, Vietnam

[8] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands

[9] Radboud Univ Nijmegen, Radboud Ctr Infect Dis, Med Ctr, Nijmegen, Netherlands

来源：

TUBERCULOSIS | 2023年 / 142卷

基金：

英国医学研究理事会; 美国国家卫生研究院;

关键词：

OPEN-LABEL; RIFAMPICIN; MOXIFLOXACIN; REGIMENS; ADULTS;

D O I：

10.1016/j.tube.2023.102361

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页数：3

共 20 条

[1]

Akhil Sahib, Tuberculosis

[2]

Ardiansyah E, 2023, medRxiv, DOI [10.1101/2023.01.08.23284316, 10.1101/2023.01.08.23284316, DOI 10.1101/2023.01.08.23284316]

[3] Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis [J].

Conradie, Francesca ;

Bagdasaryan, Tatevik R. R. ;

Borisov, Sergey ;

Howell, Pauline ;

Mikiashvili, Lali ;

Ngubane, Nosipho ;

Samoilova, Anastasia ;

Skornykova, Sergey ;

Tudor, Elena ;

Variava, Ebrahim ;

Yablonskiy, Petr ;

Everitt, Daniel ;

Wills, Genevieve H. H. ;

Sun, Eugene ;

Olugbosi, Morounfolu ;

Egizi, Erica ;

Li, Mengchun ;

Holsta, Alda ;

Timm, Juliano ;

Bateson, Anna ;

Crook, Angela M. M. ;

Fabiane, Stella M. M. ;

Hunt, Robert ;

McHugh, Timothy D. D. ;

Tweed, Conor D. D. ;

Foraida, Salah ;

Mendel, Carl M. M. ;

Spigelman, Melvin .

NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (09) :810-823

[4] High-Dose Oral and Intravenous Rifampicin for the Treatment of Tuberculous Meningitis in Predominantly Human Immunodeficiency Virus (HIV)-Positive Ugandan Adults: A Phase II Open-Label Randomized Controlled Trial [J].

Cresswell, Fiona, V ;

Meya, David B. ;

Kagimu, Enock ;

Grint, Daniel ;

Te Brake, Lindsey ;

Kasibante, John ;

Martyn, Emily ;

Rutakingirwa, Morris ;

Quinn, Carson M. ;

Okirwoth, Micheal ;

Tugume, Lillian ;

Ssembambulidde, Kenneth ;

Musubire, Abdu K. ;

Bangdiwala, Ananta S. ;

Buzibye, Allan ;

Muzoora, Conrad ;

Svensson, Elin M. ;

Aarnoutse, Rob ;

Boulware, David R. ;

Elliott, Alison M. .

CLINICAL INFECTIOUS DISEASES, 2021, 73 (05) :876-884

[5] A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus-Associated Tuberculous Meningitis: The LASER-TBM Trial [J].

Davis, Angharad G. ;

Wasserman, Sean ;

Stek, Cari ;

Maxebengula, Mpumi ;

Liang, C. Jason ;

Stegmann, Stephani ;

Koekemoer, Sonya ;

Jackson, Amanda ;

Kadernani, Yakub ;

Bremer, Marise ;

Daroowala, Remy ;

Aziz, Saalikha ;

Goliath, Rene ;

Lai Sai, Louise ;

Sihoyiya, Thandi ;

Denti, Paolo ;

Lai, Rachel P. J. ;

Crede, Thomas ;

Naude, Jonathan ;

Szymanski, Patryk ;

Vallie, Yakoob ;

Banderker, Ismail Abbas ;

Moosa, Muhammed S. ;

Raubenheimer, Peter ;

Candy, Sally ;

Offiah, Curtis ;

Wahl, Gerda ;

Vorster, Isak ;

Maartens, Gary ;

Black, John ;

Meintjes, Graeme ;

Wilkinson, Robert J. .

CLINICAL INFECTIOUS DISEASES, 2023, 76 (08) :1412-1422

[6] Cognitive Impairment in Tuberculous Meningitis [J].

Davis, Angharad G. ;

Dreyer, Anna J. ;

Albertyn, Christine ;

Maxebengula, Mpumi ;

Stek, Cari ;

Wasserman, Sean ;

Marais, Suzaan ;

Bateman, Kathleen ;

Solms, Mark ;

Joska, John ;

Wilkinson, Robert J. ;

Nightingale, Sam .

CLINICAL INFECTIOUS DISEASES, 2023, 76 (05) :842-849

[7]

Dodd Peter J, 2021, PLOS Glob Public Health, V1, pe0000069, DOI 10.1371/journal.pgph.0000069

[8] Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis [J].

Dorman, S. E. ;

Nahid, P. ;

Kurbatova, E., V ;

Phillips, P. P. J. ;

Bryant, K. ;

Dooley, K. E. ;

Engle, M. ;

Goldberg, S., V ;

Phan, H. T. T. ;

Hakim, J. ;

Johnson, J. L. ;

Lourens, M. ;

Martinson, N. A. ;

Muzanyi, G. ;

Narunsky, K. ;

Nerette, S. ;

Nguyen, N., V ;

Pham, T. H. ;

Pierre, S. ;

Purfield, A. E. ;

Samaneka, W. ;

Savic, R. M. ;

Sanne, I ;

Scott, N. A. ;

Shenje, J. ;

Sizemore, E. ;

Vernon, A. ;

Waja, Z. ;

Weiner, M. ;

Swindells, S. ;

Chaisson, R. E. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (18) :1705-1718

[9] Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis [J].

Heemskerk, A. Dorothee ;

Bang, Nguyen D. ;

Mai, Nguyen T. H. ;

Chau, Tran T. H. ;

Phu, Nguyen H. ;

Loc, Pham P. ;

Chau, Nguyen V. V. ;

Hien, Tran T. ;

Dung, Nguyen H. ;

Lan, Nguyen T. N. ;

Lan, Nguyen H. ;

Lan, Nguyen N. ;

Phong, Le T. ;

Vien, Nguyen N. ;

Hien, Nguyen Q. ;

Yen, Nguyen T. B. ;

Ha, Dang T. M. ;

Day, Jeremy N. ;

Caws, Maxine ;

Merson, Laura ;

Thinh, Tran T. V. ;

Wolbers, Marcel ;

Thwaites, Guy E. ;

Farrar, Jeremy J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (02) :124-134

[10]

Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]

← 1 2 →